These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 10933811)
1. Region-specific DNA damage by AT-specific DNA-reactive drugs is predicted by drug binding specificity. Woynarowski JM; Napier C; Trevino AV; Arnett B Biochemistry; 2000 Aug; 39(32):9917-27. PubMed ID: 10933811 [TBL] [Abstract][Full Text] [Related]
2. The DNA minor groove-alkylating cyclopropylpyrroloindole drugs adozelesin and bizelesin induce different DNA damage response pathways in human colon carcinoma HCT116 cells. Cao PR; McHugh MM; Melendy T; Beerman T Mol Cancer Ther; 2003 Jul; 2(7):651-9. PubMed ID: 12883038 [TBL] [Abstract][Full Text] [Related]
3. Mapping of DNA alkylation sites induced by adozelesin and bizelesin in human cells by ligation-mediated polymerase chain reaction. Lee CS; Pfeifer GP; Gibson NW Biochemistry; 1994 May; 33(19):6024-30. PubMed ID: 8180230 [TBL] [Abstract][Full Text] [Related]
4. The genome factor in region-specific DNA damage: the DNA-reactive drug U-78779 prefers mixed A/T-G/C sequences at the nucleotide level but is region-specific for long pure AT islands at the genomic level. Herzig MC; Rodriguez KA; Trevino AV; Dziegielewski J; Arnett B; Hurley L; Woynarowski JM Biochemistry; 2002 Feb; 41(5):1545-55. PubMed ID: 11814348 [TBL] [Abstract][Full Text] [Related]
5. Comparative activity of the cyclopropylpyrroloindole compounds adozelesin, bizelesin and carzelesin in a human tumor colony-forming assay. Hidalgo M; Izbicka E; Cerna C; Gomez L; Rowinsky EK; Weitman SD; Von Hoff DD Anticancer Drugs; 1999 Mar; 10(3):295-302. PubMed ID: 10327036 [TBL] [Abstract][Full Text] [Related]
6. Targeting critical regions in genomic DNA with AT-specific anticancer drugs. Woynarowski JM Biochim Biophys Acta; 2002 Jul; 1587(2-3):300-8. PubMed ID: 12084472 [TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomic analyses of targeting the AT-rich malaria parasite genome with AT-specific alkylating drugs. Woynarowski JM; Krugliak M; Ginsburg H Mol Biochem Parasitol; 2007 Jul; 154(1):70-81. PubMed ID: 17524501 [TBL] [Abstract][Full Text] [Related]
8. Tallimustine lesions in cellular DNA are AT sequence-specific but not region-specific. Herzig MC; Trevino AV; Arnett B; Woynarowski JM Biochemistry; 1999 Oct; 38(42):14045-55. PubMed ID: 10529251 [TBL] [Abstract][Full Text] [Related]
9. Matrix attachment region (MAR) properties and abnormal expansion of AT island minisatellites in FRA16B fragile sites in leukemic CEM cells. Jackson JA; Trevino AV; Herzig MC; Herman TS; Woynarowski JM Nucleic Acids Res; 2003 Nov; 31(21):6354-64. PubMed ID: 14576323 [TBL] [Abstract][Full Text] [Related]
10. AT-rich islands in genomic DNA as a novel target for AT-specific DNA-reactive antitumor drugs. Woynarowski JM; Trevino AV; Rodriguez KA; Hardies SC; Benham CJ J Biol Chem; 2001 Nov; 276(44):40555-66. PubMed ID: 11487576 [TBL] [Abstract][Full Text] [Related]
11. Effects of bizelesin (U-77779), a bifunctional alkylating minor groove agent, on genomic and simian virus 40 DNA. Woynarowski JM; McHugh MM; Gawron LS; Beerman TA Biochemistry; 1995 Oct; 34(40):13042-50. PubMed ID: 7548063 [TBL] [Abstract][Full Text] [Related]
12. Preclinical pharmacology of bizelesin, a potent bifunctional analog of the DNA-binding antibiotic CC-1065. Walker DL; Reid JM; Ames MM Cancer Chemother Pharmacol; 1994; 34(4):317-22. PubMed ID: 8033298 [TBL] [Abstract][Full Text] [Related]
13. Induction of AT-specific DNA-interstrand crosslinks by bizelesin in genomic and simian virus 40 DNA. Woynarowski JM; Chapman WG; Napier C; Herzig MC Biochim Biophys Acta; 1999 Feb; 1444(2):201-17. PubMed ID: 10023060 [TBL] [Abstract][Full Text] [Related]
14. Myelotoxic effects of the bifunctional alkylating agent bizelesin on human, canine and murine myeloid progenitor cells. Volpe DA; Tomaszewski JE; Parchment RE; Garg A; Flora KP; Murphy MJ; Grieshaber CK Cancer Chemother Pharmacol; 1996; 39(1-2):143-9. PubMed ID: 8995512 [TBL] [Abstract][Full Text] [Related]
15. Effects of bizelesin (U-77,779), a bifunctional alkylating minor groove binder, on replication of genomic and simian virus 40 DNA in BSC-1 cells. Woynarowski JM; Beerman TA Biochim Biophys Acta; 1997 Jul; 1353(1):50-60. PubMed ID: 9256064 [TBL] [Abstract][Full Text] [Related]
16. Different DNA lesions trigger distinct cell death responses in HCT116 colon carcinoma cells. Bai S; Goodrich DW Mol Cancer Ther; 2004 May; 3(5):613-9. PubMed ID: 15141019 [TBL] [Abstract][Full Text] [Related]
17. Antitumor drug adozelesin differentially affects active and silent origins of DNA replication in yeast checkpoint kinase mutants. Wang Y; Beerman TA; Kowalski D Cancer Res; 2001 May; 61(9):3787-94. PubMed ID: 11325853 [TBL] [Abstract][Full Text] [Related]
18. Induction of DNA damage responses by adozelesin is S phase-specific and dependent on active replication forks. Liu JS; Kuo SR; Beerman TA; Melendy T Mol Cancer Ther; 2003 Jan; 2(1):41-7. PubMed ID: 12533671 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of initiation of simian virus 40 DNA replication in infected BSC-1 cells by the DNA alkylating drug adozelesin. Cobuzzi RJ; Burhans WC; Beerman TA J Biol Chem; 1996 Aug; 271(33):19852-9. PubMed ID: 8702695 [TBL] [Abstract][Full Text] [Related]
20. Bizelesin, a bifunctional cyclopropylpyrroloindole alkylating agent, inhibits simian virus 40 replication in trans by induction of an inhibitor. McHugh MM; Kuo SR; Walsh-O'Beirne MH; Liu JS; Melendy T; Beerman TA Biochemistry; 1999 Aug; 38(35):11508-15. PubMed ID: 10471303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]